Trial Profile
Thalidomide-Dexamethasone for Multiple Myeloma.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 09 Nov 2018
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Thalidomide (Primary)
- Indications Multiple myeloma; Smoldering multiple myeloma
- Focus Therapeutic Use
- 13 Jul 2009 New trial record